Driving impairment
This medicine may affect your ability to drive or use machines.
Leaflet BYANNLI 700mg prolonged-release suspension for injection
- Product code:
- W68385001
- Quantity:
- 1
- Indicated for:
- schizophrenia; bipolar disorder
- Route of administration:
- injectable
- Substance:
- paliperidone (antipsychotic)
- ATC
- N05AX13 — Nervous system | Antipsychotics | Other antipsychotics
Precautions:
Dizziness / vertigo
This medicine may cause dizziness or vertigo.
Hyperglycemia
This medicine may increase blood sugar.
Cardiac risk / QT prolongation / arrhythmias
This medicine may increase the risk of heart rhythm disturbances.
Seizure risk
This medicine may increase the risk of seizures.
Drowsiness / sedation
This medicine may cause drowsiness or reduced alertness.
Paliperidone is an antipsychotic medication used for the treatment of schizophrenia and schizoaffective disorder. It belongs to the class of atypical antipsychotics and works by regulating the activity of neurotransmitters in the brain, such as dopamine and serotonin.
The medication is administered orally or as long-acting injectable formulations, as directed by your doctor. It is important to follow the prescribed dosage and not to discontinue treatment without consulting your doctor.
Side effects may include drowsiness, dizziness, weight gain, gastrointestinal disturbances, or, in rare cases, neuroleptic malignant syndrome.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as cardiovascular diseases or diabetes, to ensure the safe use of paliperidone.
The medication is administered orally or as long-acting injectable formulations, as directed by your doctor. It is important to follow the prescribed dosage and not to discontinue treatment without consulting your doctor.
Side effects may include drowsiness, dizziness, weight gain, gastrointestinal disturbances, or, in rare cases, neuroleptic malignant syndrome.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as cardiovascular diseases or diabetes, to ensure the safe use of paliperidone.
General data about BYANNLI 700mg
- Substance:
- paliperidone
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W68385001
- Concentration:
- 700mg
- Pharmaceutical form:
- prolonged-release suspension for injection
- Quantity:
- 1
- Product type:
- Original
- Price:
- 4585.70 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for paliperidone
Concentrations available for paliperidone
- 1000mg
- 100mg
- 12mg
- 150mg
- 175mg
- 25mg
- 263mg
- 350mg
- 3mg
- 50mg
- 525mg
- 6mg
- 700mg
- 75mg
- 9mg